Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001613780-25-000011
Filing Date
2025-04-30
Accepted
2025-04-30 16:02:22
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dbvt-20250331.htm   iXBRL 10-Q 776278
2 EX-3.1 exhibit31-bylawsxdbv10xq_u.htm EX-3.1 92432
3 EX-31.1 exhibit311-dbv_10xqxq1x2025.htm EX-31.1 10292
4 EX-31.2 exhibit312-dbv_10xqxq1x2025.htm EX-31.2 10256
5 EX-32.1 exhibit321-dbv_10xqxq1x2025.htm EX-32.1 6427
  Complete submission text file 0001613780-25-000011.txt   5185131

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dbvt-20250331.xsd EX-101.SCH 53328
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dbvt-20250331_cal.xml EX-101.CAL 73492
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dbvt-20250331_def.xml EX-101.DEF 174937
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dbvt-20250331_lab.xml EX-101.LAB 528270
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dbvt-20250331_pre.xml EX-101.PRE 355694
82 EXTRACTED XBRL INSTANCE DOCUMENT dbvt-20250331_htm.xml XML 585610
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36697 | Film No.: 25894789
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)